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Gardner’s syndrome (GS) is a dysplasia characterized by neoformations of the intestine, soft tissue, and osseous tissue. Endocrine
neoplasms have occasionally been reported in association with GS. Adrenal masses in GS are rare, and few have displayed clinical
manifestations. In the current paper, The authors report a 37-year-old male patient with GS including familial adenomatous
polyposis (FAP) and mandible osteoma who presented with an incidental adrenal mass. Computerized tomography adrenal scan
identiﬁed bilateral masses. Functional analyses showed a hormonal secretion pattern consistent with pre-Cushing’s syndrome.
Other extraintestinal manifestations were hypertrophy of the pigmented layer of the retina and histiocytoﬁbroma in the right leg.
This paper describes a rare association of adrenocortical secreting mass in an old male patient with Gardner syndrome.
1.Introduction
Gardner’s syndrome (GS) is a variant of familial adenomato-
sis polyposis (FAP), which aﬀects one in 8300 individuals
and one in 7500 births in the United States [1]. The
disease is characterized by colonic polyps and extracolonic
manifestations. The polyps typically develop in adolescence
and undergo malignant change between the third and ﬁfth
decades of life. The extracolonic manifestations include
osteomas, desmoids tumors, epidermoid cysts, and malig-
nancies [2].
ItisbelievedthatGSandfamilialadenomatouspolyposis
are variants of the same disorder, since they share the same
genetic alterations [3]. The fact that GS is associated with
extracolonic manifestations may be explained by a variable
penetrance of a common mutation. The disorder is linked to
band 5q21-q22, the adenomatous polyposis coli locus (APC
gene) [4]. More than 1400 diﬀerent mutations of this gene
have been reported. These mutations have a nearly complete
penetrance of the colonic phenotype, but a variable pene-
trance of the extracolonic manifestations of the disease [4].
Among rare extracolonic manifestations of AFP,
endocrine neoplasms of the adrenal cortex have occasionally
been reported.
We describe a pre-Cushing’s syndrome in a 37-year-old
male patient with GS who presented with an incidental
adrenal mass.
2.CaseReport
A 37-year-old male with a 6-year history of AFP syndrome
was referred to our endocrinologist outpatients for evalua-
tion of an adrenal mass.
In 2003, the patient was found to have multiple ade-
nomatous polyps in the colon as well as the rectum. A
total proctocolectomy with ileal-anal pouch anastomosis was
performed. The pathology of the specimen showed more
than 100 colorectal adenomatous polyps, several of them
showing carcinoma in situ and conﬁrmed the diagnosis of
FAP.
The patient’s mother previously died of colon cancer at
the age of 39 years as well as his father and paternal uncle of2 Case Reports in Medicine
Figure 1: Partial pedigree of the family and mutation segregation.
Square and circle symbols represent male and female, respectively.
The genotypes of the exon ii polymorphism are shown under the
symbols. Arrow: proband. Grey symbols: asymptotic carriers of the
mutation.
Figure 2: CT scan of the abdomen demonstrating a 2.5 × 4.0cm
mass in the right adrenal gland.
his mother. This patient has one sister and one brother who
died at age 19 and 27 years, respectively. In his family, he also
has one sister and one daughter who have the mutation gene
but are asymptomatic (Figure 1).
The mutation screening showed heterozygous mutation
in exon 15 at the codon 2016-2017 Del AT, p. Ser 672fsX5 at
the extreme 5∗ end of the gene, the adenomatous polyposis
coli (APC) gene.
After being operated on, he began regular followup
endoscopic examinations of intestinal and gastroduodenal
polyps, which were insuﬃciently destroyed as they rose. The
pathological evaluation revealed a tubulovillous adenoma
with high-grade dysplasia. A routine abdominal computed
tomography (CT) scan incidentally identiﬁed a 2.5 × 4.0cm
right adrenal (Figure 2).
Table 1: Chemistry proﬁle of our patient.
Chemistry proﬁle
Creatinine = 83,2µmol/L
Urea = 3,84mmo/L
Serum electrolytes: natremia = 135,9mmo/L, kalemia =
4,77mmo/L
Hemoglobin = 14,2g/100mL
White blood cell blood = 5910 plaquette = 160.000
Cholesterol = 3,92mmol/L triglyceride = 1,16mmol/L
Calcium = 2,4mmol/L
Phosphorus = 1,15mmol/L
Table 2: Endocrinological data of our patient.
Plasma cortisol at 8:00 AM = 12,7µg/dL (normal range:
6,2–19,4µg/dL)
Plasma cortisol at 16:00 = 11,5µg/dL
ACTH level = 12,2pg/mL (normal range 10–50).
Plasma aldosterone = 72, 7pM/L (normal range: 274PM/l) =
26pg/mL
Rennin was = 14,5ng/L (normal range: 8,5ng/L)
Urinary metanephrines = 20.00nmol/cr (normal range: 10–200)
Urinary normetanephrine = 96.00nmol/cr (normal range:
40–250)
This patient was referred to our endocrinologist outpa-
tients for exploration.
Physical examination was unremarkable except for a
tumefaction of the left mandible. His blood pressure was
130/75mmHg. His Weight was 92Kg, his height 1,77m, and
his body mass index was 30,8Kg/m2.
The neurologic examination and the remainder of the
systemic examination were normal. Signs of Cushing’s syn-
drome were not noted. Chemistry proﬁle was unremarkable
(Table 1).
Endocrinological data showed alterations of the normal
diurnal variation of cortisol (Table 2). Cortisolemia was
not suppressed by 0,5mg of dexamethasone given every
6 hour for 48 hours (plasma cortisol level was 14,4µg/dL
after suppression). Computerized tomography adrenal scan
identiﬁed bilateral masses, with a spontaneous density at
6UH. These masses have homogeneous density and mea-
sured 3,5cm in the right adrenal and 1cm in the left adrenal.
These criteria were in favor of benign masses. Therefore,
this patient was found to have bilateral adrenocortical
mass. The functional analyses showed a hormonal secretion
pattern consistent with pre-Cushing’s syndrome. Despite the
character of secreting masses that indicate surgery, we opted
for observation and recommended a 1-year interval CT.
In three months, the masses did not changed in size or
character, and given the risk of perioperative complications,
observation was again recommended. The patient continues
to fare well.Case Reports in Medicine 3
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Figure 3: Panoramic radiograph shows an osteoma of the left angle
of the mandible.
Our patient had another extra intestinal manifestations
including:
(i) osteoma in the mandible without impacted or
unerupted teeth objectiﬁed in the panoramic radio-
graph (Figure 3);
(ii) a typical hypertrophy of the pigmented layer of the
retina;
(iii) the dermatological ﬁnding revealed histiocytoﬁ-
broma in the right leg which was surgically removed.
3. Discussion
Gardner’s syndrome, a variant of familial adenomatous
polyposis, represents a multisystemic disease and disorder of
growth [5].
The primary risk for patients with FAP and its variants is
the development of colorectal cancer; however, there is also
an increased incidence of other tumors, including adrenal
masses.
The polyp formation starts at puberty but diagnosis
is usually made in the third decade, while the malignant
transformationreaches100%bythefourthdecadeoflife[3].
Although not common, endocrine neoplasms such as
parathyroid, pituitary, pancreatic islet cell, and adrenal
neoplasms have all been described in patients with GS [2].
The ﬁrst case of a FAP patient with an adrenal adenoma
was published almost a century ago [4]. As a result of
technological advances in imaging techniques such as CT
and MRI during the last decades, new data have become
available regarding the prevalence of adrenal masses in both
the general population and patients with FAP.
7% of patients with FAP or its variants have adrenal
masses, compared with only 3% of the general public [4, 6].
Although the prevalence of adrenal masses in FAP patients
a r et w ot of o u rt i m e sa sh i g ha si nt h eg e n e r a lp o p u l a t i o n ,
the clinical presentation and biological behavior do not seem
to be diﬀerent [4, 7].
Most adrenal lesions are not functional. Functional
lesions typically secrete cortisol. Because most endocrine-
associated tumors in patients with GS occur without symp-
toms, most cases are discovered incidentally or at autopsy.
A review of the literature resulted in the identiﬁcation of
17 cases of adrenal neoplasms (13 adenomas, 4 carcinomas)
in patients with GS [8].
Only 4 patients, however, were symptomatic. They
developed weight gain, hypertension, and headaches but did
not have electrolyte abnormalities. Two of the patients had
adrenal cortical carcinomas, and 2 had adrenal adenomas
[8].
In all the 4 cases, the symptoms were consistent with
cortisol hypersecretion or adrenal Cushing’s syndrome [8].
While the overwhelming majority of these masses are
benign and nonfunctional, there are reports of more aggres-
sive and functional tumors in patients with FAP or its
variants [9, 10].
Such rare cases are uncommon and highlight the relative
risks of adrenal tumors versus other risks associated with
treatment for FAP: one study of 132 FAP patients found that
only one patient (0,9%) died of adrenal carcinoma, while
4,5% died from perioperative complications as a result of
various abdominal operations [11].
Although the natural history is similar to lesions occur-
ring sporadically, familial adenomatous polyposis-associated
adrenal incidentaloma should warrant long term followup.
In this rare condition, the development of a rigorous reg-
imen will require evidence from worldwide patient cohorts.
However, a tailored schema is suggested as a consistent
basis for future modiﬁcation [7]. Data on genetic analysis
are limited, and only three mutations have been described
(codons 1061, 1542, and 1981). The latter was associated
with multiple and bilateral adenomas [4].
4. Conclusion
In conclusion, we presented a case of GS with an unusual
clinical presentation of an adrenal tumor incidentally dis-
covered. The hormonal ﬁnding conﬁrmed the pre-Cushing’s
syndrome; the computed tomography showed bilateral
adrenal masses and were in favor of the benign. Surgery
was indicated for our patient, but we opted for observation,
regularly taking into account the risk of perioperative
complications. However, our patient is likely to develop
complications from Cushing’s syndrome.
Adrenal tumors were more common in FAP than in the
general population, but require the same followup.
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